Compare AHRT & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AHRT | AUTL |
|---|---|---|
| Founded | 1979 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.7M | 431.2M |
| IPO Year | 2013 | 2025 |
| Metric | AHRT | AUTL |
|---|---|---|
| Price | $5.14 | $1.20 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $7.00 | ★ $8.50 |
| AVG Volume (30 Days) | ★ 1.9M | 1.4M |
| Earning Date | 05-06-2026 | 03-27-2026 |
| Dividend Yield | ★ 10.51% | N/A |
| EPS Growth | N/A | ★ 28.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $10,120,000.00 |
| Revenue This Year | $840.79 | $669.62 |
| Revenue Next Year | $10.97 | $79.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 496.00 |
| 52 Week Low | $5.30 | $1.11 |
| 52 Week High | $6.11 | $2.70 |
| Indicator | AHRT | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 28.97 | 31.66 |
| Support Level | N/A | N/A |
| Resistance Level | $5.98 | $1.52 |
| Average True Range (ATR) | 0.24 | 0.07 |
| MACD | -0.06 | -0.03 |
| Stochastic Oscillator | 2.56 | 8.11 |
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.